Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Gynecol Endocrinol ; 33(5): 342-348, 2017 May.
Article in English | MEDLINE | ID: mdl-28277114

ABSTRACT

Premenstrual disorders (PMD) can affect women throughout their entire reproductive years. In 2016, an interdisciplinary expert meeting of general gynecologists, gynecological endocrinologists, psychiatrists and psychologists from Switzerland was held to provide an interdisciplinary algorithm on PMD management taking reproductive stages into account. The Swiss PMD algorithm differentiates between primary and secondary PMD care providers incorporating different levels of diagnostic and treatment. Treatment options include cognitive behavioral therapy, alternative therapy, antidepressants, ovulation suppression and diuretics. Treatment choice depends on prevalent PMD symptoms, (reproductive) age, family planning, cardiovascular risk factors, comorbidities, comedication and the woman's preference. Regular follow-ups are mandatory.


Subject(s)
Algorithms , Premenstrual Syndrome/therapy , Complementary Therapies/methods , Complementary Therapies/standards , Consensus , Female , Humans , Interdisciplinary Communication , Phytotherapy/methods , Phytotherapy/standards , Premenstrual Syndrome/diagnosis , Premenstrual Syndrome/epidemiology , Premenstrual Syndrome/psychology , Switzerland
2.
J Electrocardiol ; 47(5): 745-7, 2014.
Article in English | MEDLINE | ID: mdl-24768036

ABSTRACT

Since 2005 Professor Antonio Bayés de Luna and Dr Miquel Fiol have invited experts in electrocardiography to consensus meeting in Barcelona and Mallorca. The meetings have resulted in consensus papers related to different electrocardiography topics. An interview with Professor Bayés de Luna was conducted.


Subject(s)
Cardiology/history , Electrocardiography/history , Cardiology/education , Congresses as Topic , History, 21st Century , Humans , Spain
3.
Interact Cardiovasc Thorac Surg ; 31(3): 287-298, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32747932

ABSTRACT

OBJECTIVES: A significant gap in our knowledge of how to manage pulmonary ground-glass opacities (GGOs) still exists. Accordingly, there is a lack of consensus among clinicians on this topic. The Italian Society of Thoracic Surgery (Società Italiana di Chirurgia Toracica, SICT) promoted a national expert meeting to provide insightful guidance for clinical practice. Our goal was to publish herein the final consensus document from this conference. METHODS: The working panel of the PNR group (Pulmonary Nodules Recommendation Group, a branch of the SICT) together with 5 scientific supervisors (nominated by the SICT) identified a jury of expert thoracic surgeons who organized a multidisciplinary meeting to propose specific statements (n = 29); 73 participants discussed and voted on statements using a modified Delphi process (repeated iterations of anonymous voting over 2 rounds with electronic support) requiring 70% agreement to reach consensus on a statement. RESULTS: Consensus was reached on several critical points in GGO management, in particular on the definition of GGO, radiological and radiometabolic evaluation, indications for a non-surgical biopsy, GGO management based on radiological characteristics, surgical strategies (extension of pulmonary resection and lymphadenectomy) and radiological surveillance. A list of 29 statements was finally approved. CONCLUSIONS: The participants at this national expert meeting analysed this challenging topic and provided a list of suggestions for health institutions and physicians with practical indications for GGO management.


Subject(s)
Consensus , Disease Management , Lung Neoplasms/surgery , Societies, Medical , Thoracic Surgery , Thoracic Surgical Procedures/methods , Humans , Italy
4.
Zhongguo Zhen Jiu ; 40(4): 450-4, 2020 Apr 12.
Article in Zh | MEDLINE | ID: mdl-32275379

ABSTRACT

The indication of bloodletting therapy was determined based on the multi-dimensional evidence assessment, which could provide guidance for the clinical application of bloodletting therapy. The literature of bloodletting therapy was comprehensively collected by retrieval in CNKI, Wanfang and VIP databases (until February 23, 2019), modern books in Library of Tianjing University of TCM and the Chinese Medical Code (Fifth Edition). The disease spectrum of bloodletting therapy was determined by self-designed questionnaire survey e-mailed to relevant experts. The indication of bloodletting therapy was determined by Delphi expert meeting. As a result, 746 pieces of ancient literature and 32 775 modern literature were included. The indications of bloodletting therapy based on the multi-dimensional evidence assessment include herpes zoster, acne, acute tonsillitis, vascular headache, varicose veins of lower extremities, acute lumbar sprain, early erysipelas, wheat swelling, exogenous fever of children, stroke, which are mainly the syndromes of blood stasis, toxin, excess and heat.


Subject(s)
Bloodletting , Medicine, Chinese Traditional , Humans
5.
Berg Huttenmannische Monatshefte ; 165(10): 490-492, 2020.
Article in German | MEDLINE | ID: mdl-33082597

ABSTRACT

Existing since 1964, the Committee for Mineral Processing is one of the most important units of the Austrian Mining Association. The Committee is engaged in publishing technical information concerning mineral processing, both in articles and in conferences. Since 2003 the Comittee has been performing the expert meeting for mineral processing at the Montanunversitaet of Leoben. This enables an intensive exchange of experience on different problems of mineral processing. Special efforts are made to integrate young technicians and students.

6.
Cancer Chemother Pharmacol ; 83(2): 301-318, 2019 02.
Article in English | MEDLINE | ID: mdl-30460489

ABSTRACT

INTRODUCTION: Despite the large use of nab-paclitaxel as a treatment option in metastatic breast cancer (MBC) across different countries, no definitive data are available in particular clinical situations. AREAS COVERED: Efficacy, safety and schedule issues concerning available literature on nab-paclitaxel in advanced breast cancer and in specific subgroups of patients have been discussed and voted during an International Expert Meeting. Ten expert specialists in oncology, with extensive clinical experience on Nab-P and publications in the field of MBC have been identified. Six scientific areas of interest have been covered, generating 13 specific Statements for Nab-P, after literature review. For efficacy issues, a summary of research quality was performed adopting the GRADE algorithm for evidence scoring. The panel members were invited to express their opinion on the statements, in case of disagreement all the controversial opinions and the relative motivations have been made public. EXPERT OPINION: Consensus was reached in 30.8% of the Nab-P statements, mainly those regarding safety issues, whereas ones regarding efficacy and schedule still remain controversial areas, requiring further data originated by the literature.


Subject(s)
Albumins/therapeutic use , Breast Neoplasms/drug therapy , Paclitaxel/therapeutic use , Practice Guidelines as Topic/standards , Receptor, ErbB-2/metabolism , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Consensus , Female , Humans , Survival Rate , Treatment Outcome
7.
Cancer Treat Rev ; 71: 76-87, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30366202

ABSTRACT

Thymic epithelial tumors (TETs) are a heterogenous group of rare tumors, with a complex histopatological classification. Furthermore, the recent introduction of the first TNM staging system, that is scheduled to replace the Masaoka-Koga system, may create further difficulties in TET management, that remains challenging. Several guidelines for treatment of TETs are available and provide recommendations based mainly on non randomized trials and retrospective or limited series. Often the lack of evidence leads to formulation of indications based on expert opinions. As for other rare cancers it is crucial to create networks to coordinate the work among centres involved in treatment of these diseases in order to offer the best diagnostic and therapeutic tools. For this purpose, in 2014 a network named TYME (ThYmic MalignanciEs), was founded in Italy with the aim of improving care and research in TETs. In September 2017 a panel of multidisciplinary experts from TYME network and from other Italian centres strongly involved in TET diagnosis and treatment convened a first Italian Expert meeting together with representatives of association for patients affected by rare thoracic cancers Tu.To.R, to explore how these tumors are managed in the different centres of Italy compared to ESMO guidelines. In this paper we summarize the issues discussed during that meeting and we propose recommandations based on Masaoka Koga and the new TNM staging system.


Subject(s)
Neoplasms, Glandular and Epithelial/diagnosis , Neoplasms, Glandular and Epithelial/therapy , Thymus Neoplasms/diagnosis , Thymus Neoplasms/therapy , Autoimmune Diseases/etiology , Chemotherapy, Adjuvant/methods , Contrast Media , Female , Humans , Male , Neoplasm Recurrence, Local , Neoplasms, Glandular and Epithelial/diagnostic imaging , Neoplasms, Glandular and Epithelial/pathology , Thymus Neoplasms/diagnostic imaging , Thymus Neoplasms/pathology , Tomography, X-Ray Computed/methods
8.
World Neurosurg ; 108: 254-263, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28882715

ABSTRACT

BACKGROUND: Motor cortex stimulation (MCS) was introduced in the early 1990s by Tsubokawa and his group for patients diagnosed with drug-resistant, central neuropathic pain. Inconsistencies concerning the details of this therapy and its outcomes and poor methodology of most clinical essays divide the neuromodulation society worldwide into "believers" and "nonbelievers." A European expert meeting was organized in Brussels, Belgium by the Benelux Neuromodulation Society in order to develop uniform MCS protocols in the preoperative, intraoperative, and postoperative courses. METHODS: An expert meeting was organized, and a questionnaire was sent out to all the invited participants before this expert meeting. An extensive literature research was conducted in order to enrich the results. RESULTS: Topics that were addressed during the expert meeting were 1) inclusion and exclusion criteria, 2) targeting and methods of stimulation, 3) effects of MCS, and 4) results from the questionnaire. CONCLUSIONS: Substantial commonalities but also important methodologic divergencies emerged from the discussion of MCS experts from 7 European Centers. From this meeting and questionnaire, all participants concluded that there is a need for more homogenous standardized protocols for MCS regarding patient selection, implantation procedure, stimulation parameters, and follow-up-course.


Subject(s)
Chronic Pain/therapy , Electric Stimulation Therapy/methods , Motor Cortex , Neuralgia/therapy , Belgium , Congresses as Topic , Europe , Expert Testimony , Humans , Patient Selection , Prognosis , Surveys and Questionnaires , Transcranial Magnetic Stimulation
SELECTION OF CITATIONS
SEARCH DETAIL